Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-IMG-171168

Xenbase Image ID: 171168


Fig. 5. Pgam5 is required for anterior inhibition of Wnt/β-Catenin signaling and ectodermal anterior-posterior patterning. (A) The prospective neural plate was explanted from embryos injected with 0.4 pmol Pgam5 MO1 or controlMOat NF stage 11.5 and dissected into anterior, mid and posterior thirds as indicated in the schematic. Active dephosphorylated β-Catenin (ABC) was detected in an anterior to posterior gradient in lysates from control dorsal explants. The blots show one representative experiment; data in the graph are average ratios±s.d. of ABC/β-Catenin from four independent experiments (*P<0.05, separate variances t-test). (B) Embryos were injected into one dorsal blastomere at the four-cell stage with 0.4 pmol Pgam5 MO1 or control MO, pCS2+ lacZ as lineage tracer and PGAM5 RNAor PGAM5-H105ARNAas indicated.Embryoswere stained for β-galactosidase to identify the injected side (asterisk) and analyzed for the expression of krox20 and otx2 at NF stage 21 by in situ hybridization. Images show representative embryos; the corresponding pattern is schematically shown in the upper right corner. The graph summarizes the results from five independent experiments (**P<0.01, *P<0.05, n.s. not significant, Wilcoxon-Rank-Sum test).

Image published in: Rauschenberger V et al. (2017)

Copyright © 2017. Image reproduced with permission of the publisher and the copyright holder. This is an Open Access article distributed under the terms of the Creative Commons Attribution License.

GeneSynonymsSpeciesStage(s)Tissue
otx2.Lotx-2, otx2-a, otx2-b, otxA, Xotx-2, Xotx2X. laevisThroughout NF stage 21anterior neural tube
anterior
egr2.LEGR-2, Krox-20, krox20, XKr20, XKrox-20X. laevisThroughout NF stage 21presumptive rhombomere

Image source: Published

Larger Image
Printer Friendly View

Return to previous page